# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-015208
Filing Date
2022-03-25
Accepted
2022-03-25 17:00:33
Documents
58
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | f10k2021_actiniumpharma.htm iXBRL | 10-K | 1184903
2 | CONSENT OF MARCUM LLP | f10k2021ex23-1_actinium.htm | EX-23.1 | 2129
3 | CERTIFICATION | f10k2021ex31-1_actinium.htm | EX-31.1 | 8570
4 | CERTIFICATION | f10k2021ex31-2_actinium.htm | EX-31.2 | 8804
5 | CERTIFICATION | f10k2021ex32-1_actinium.htm | EX-32.1 | 3794
6 | CERTIFICATION | f10k2021ex32-2_actinium.htm | EX-32.2 | 3766
| Complete submission text file | 0001213900-22-015208.txt |  | 4499003

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | atnm-20211231.xsd | EX-101.SCH | 43286
8 | XBRL CALCULATION FILE | atnm-20211231_cal.xml | EX-101.CAL | 27070
9 | XBRL DEFINITION FILE | atnm-20211231_def.xml | EX-101.DEF | 198992
10 | XBRL LABEL FILE | atnm-20211231_lab.xml | EX-101.LAB | 412616
11 | XBRL PRESENTATION FILE | atnm-20211231_pre.xml | EX-101.PRE | 212275
52 | EXTRACTED XBRL INSTANCE DOCUMENT | f10k2021_actiniumpharma_htm.xml | XML | 391363

Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36374 | Film No.: 22772177
SIC: 2834 Pharmaceutical Preparations